Study says recurring C. diff infections up 189% from 2001 to 2012

Findings indicate multiple recurring C. diff infections place an increased burden on healthcare system


Multiple recurring Clostridium difficile infections increased 189 percent from 2001 to 2012, according to an article on the Becker's Infection Control & Clinical Quality website.

In contrast, the incidence of C. diff infections rose by about 43 percent.

Researchers labeled the C. diff infections as "multiple recurrent" when the patients were teated with three courses of antibiotics, with little time between each course.

The study suggested the findings indicate multiple recurring C. diff infections place an increased burden on the healthcare system.

Read the article.

 

 



July 12, 2017


Topic Area: Infection Control


Recent Posts

The HVAC Dilemma: To Repair or Replace?

Healthcare facilities that keep repairing and optimizing aging systems past their useful life spend money on a problem they cannot solve without capital investment.


Department of Veterans Affairs Signs Lease for Community-Based Outpatient Clinic in Kentucky

Construction and facility preparation are expected to be completed by the winter of 2027, and the first patient should be seen by spring 2028.


Cameron Regional Medical Center Falls Victim to Ransomware Attack

CRMC is not currently aware of any evidence to suggest that any information has been fraudulently misused.


3 Pillars of Stronger Cybersecurity in Healthcare

These strategies can help healthcare facilities stay ahead of evolving cyber threats.


Meridian Acquires Medical Office Building in Pasadena, CA

The property was acquired for approximately $13.35 million.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.